1. Home
  2. ONTF vs HELP Comparison

ONTF vs HELP Comparison

Compare ONTF & HELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ON24 Inc.

ONTF

ON24 Inc.

HOLD

Current Price

$8.11

Market Cap

347.2M

Sector

Technology

ML Signal

HOLD

HELP

Cybin Inc. Common Stock

N/A

Current Price

$4.99

Market Cap

281.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONTF
HELP
Founded
1998
N/A
Country
United States
Canada
Employees
N/A
50
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
347.2M
281.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ONTF
HELP
Price
$8.11
$4.99
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
$8.10
$95.00
AVG Volume (30 Days)
599.1K
1.2M
Earning Date
05-06-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
32.67
N/A
EPS
N/A
N/A
Revenue
$139,312,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.51
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$4.29
52 Week High
$8.11
$8.55

Technical Indicators

Market Signals
Indicator
ONTF
HELP
Relative Strength Index (RSI) 67.87 44.86
Support Level $7.84 $4.47
Resistance Level N/A $5.02
Average True Range (ATR) 0.02 0.33
MACD -0.01 0.06
Stochastic Oscillator 88.89 66.04

Price Performance

Historical Comparison
ONTF
HELP

About ONTF ON24 Inc.

ON24 Inc provides a cloud-based intelligent engagement platform that combines experiences with personalization and content, to enable sales and marketing organizations to capture and act on connected insights at scale. The company's platform offers a portfolio of interactive and hyper-personalized digital experience products that create and capture actionable, real-time data at scale from millions of professionals to provide businesses with buying signals and behavioral insights to efficiently convert prospects into customers. It provides solutions to Financial services, Life Sciences, Life sciences, Insurance, Technology, Associations, and Others. Geographically, the company derives maximum revenue from United States, and also has its presence in EMEA and Other Countries.

About HELP Cybin Inc. Common Stock

Helus Pharma Inc is a clinical-stage pharmaceutical company developing proprietary novel serotonergic agonists (NSAs), which are synthetic molecules designed to activate serotonin pathways associated with neuroplasticity. These compounds are being investigated for potential use in the treatment of depression, anxiety, and other mental health conditions, areas where there is an unmet medical need. It aims to provide treatments designed for mental health disorders. The company is currently developing HLP003, a proprietary NSA, in Phase 3 clinical development for the adjunctive treatment of substantial depressive disorder. It operates in Canada, the United States, the United Kingdom, and Ireland.

Share on Social Networks: